Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
14.22
+0.74 (5.49%)
At close: Oct 8, 2025, 4:00 PM EDT
14.11
-0.11 (-0.77%)
After-hours: Oct 8, 2025, 5:51 PM EDT
Avalo Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$30.14
Upside
+111.95%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +181.29% | Sep 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $25 | Strong Buy | Maintains | $15 → $25 | +75.81% | Sep 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +5.49% | Jun 2, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +61.74% | Mar 25, 2025 |
| Stifel | Stifel | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +153.16% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $48 | Buy | Initiates | $48 | +237.55% | Feb 28, 2025 |
| BTIG | BTIG | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +181.29% | Dec 19, 2024 |
| LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +68.78% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 24, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $35 | Hold → Buy | Upgrades | $35 | +146.13% | Apr 16, 2024 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 27, 2023 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $2,160 → $180 | Buy → Hold | Downgrades | $2,160 → $180 | +1,165.82% | Jun 27, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $4,080 → $2,160 | Buy | Maintains | $4,080 → $2,160 | +15,089.87% | May 10, 2023 |
| Jefferies | Jefferies | Hold → Sell Downgrades $720 | Hold → Sell | Downgrades | $720 | +4,963.29% | Feb 8, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.